RxDoctor Payments Data

Doris Carmichael

Family · Eastpoint, FLNPI 1407112063

Payments from drug & device makers

$903in general payments, 2019–2025

Across 42 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$392
  • AbbVie$144
  • GSK$139
  • Lilly USA, LLC$56
  • UCB, Inc.$44
  • Supernus Pharmaceuticals, Inc.$24
  • plus $105 from 7 others

What the payments were for

  • Food & beverage$903100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$903 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$859
Medicare patients
44
Services billed
76

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide61$66,107
JardianceEmpagliflozin42$52,613
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$40,500
EliquisApixaban28$37,636
MounjaroTirzepatide27$30,355
EntrestoSacubitril/Valsartan14$13,458
Repatha SureclickEvolocumab12$12,325
FarxigaDapagliflozin Propanediol13$10,806
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,562
Gabapentin86$2,187
Omeprazole94$1,618
Albuterol Sulfate HfaAlbuterol Sulfate56$1,605
Bupropion XlBupropion Hcl32$1,405
Rosuvastatin Calcium99$1,290
Pantoprazole Sodium112$1,260

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$392$66,10761 claims
GSKTrelegy Ellipta$139$40,50045 claims
PfizerEliquis$15$37,63628 claims
Lilly USA, LLCMounjaro$56$30,35527 claims
AstraZenecaFarxiga$12$10,80613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Eastpoint

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →